Article Text

PDF

Review: some but not all topical antimicrobial agents improve the rate of healing of chronic wounds
  1. Leonard Leibovici, MD
  1. Rabin Medical Center, Petah-Tiqva, Israel

    Statistics from Altmetric.com

    
 
 QUESTION: Are systemic and topical antimicrobial agents effective for healing chronic wounds (venous leg ulcers, pressure ulcers, diabetic foot ulcers, and pilonidal sinuses)?

    Data sources

    Studies were identified by searching 19 electronic databases, including Medline and CINAHL, from their inception to January 2000. Conference abstracts, journals, and bibliographies of included studies were handsearched, and experts were contacted.

    Study selection

    Randomised controlled trials (RCTs) and non-randomised trials with a control group were selected if patients had or were at risk for developing diabetic foot ulcers, pressure ulcers, chronic leg ulcers, pilonidal sinuses, non-healing surgical wounds, or chronic cavity wounds; systemic or topical antimicrobial preparations (antibiotic, antifungal, or antiviral agents) intended to prevent or heal wounds were studied; and objective measurement of wound healing, change in skin condition, or development of new lesions was reported.

    Data extraction

    Data were extracted on study quality and characteristics, participants, interventions, outcomes, and adverse events.

    Main results

    30 trials (25 RCTs) met the inclusion criteria. Trials were grouped according to wound type (table); data were not combined because of study differences. For topical agents for venous ulcers, allopurinol powder, dimethyl sulfoxide powder, silver impregnated charcoal dressing, and tripeptide-copper or silver sulfadiazine improved complete healing of the ulcer area more than placebo or other topical agents. Oxyquinolone ointment improved complete healing of pressure ulcers. Excision with insertion of a gentamicin impregnated sponge and pressure dressing also showed improvement in wound healing for pilonidal sinuses.

    Treatment of chronic wounds or ulcers with systemic antimicrobial or topical agents*

    Conclusion

    Healing of chronic wounds is improved by some topical antimicrobial agents, but few systemic agents show improvements.

    Commentary

    Chronic wounds are a common cause of morbidity, and their cost of care is high. For example, the annual incidence of foot ulcers in patients with diabetes is about 6%, and 16% of these patients require amputation.1 The incidence of pressure sores in a well staffed internal medicine ward was 4%.2 The role of infection and colonisation in preventing wound healing is uncertain, and so is the role of antimicrobial agents in promoting recuperation.

    The systematic review by O'Meara et al on antimicrobial agents for treatment of chronic wounds is excellent, with a well defined clinical question, a comprehensive search strategy, and unambiguous criteria for inclusion of studies. The included studies are well described, which allows readers to form their own opinion. The discussion is relevant and comprehensive for both methods and pathophysiological content. Unfortunately, the review offers few recommendations to change clinical practice because little can be learnt from the original studies. Most of them had a small sample size, weak methodology, and unclear biological hypotheses. The abstract cannot do justice to the review by enumeration of positive and negative results. To gain a true insight, the review itself should be read.

    Nevertheless, several messages can be highlighted. Overall, systemic antibiotics did not promote healing. However, an effect of antibiotic treatment on healing might have been missed because of a small sample size in some studies. Given the potential to induce resistance, the possible adverse effects, and the lack of evidence for effect, systemic antibiotic treatment should be given only for clear indications of a systemic or local infection.

    Topical antimicrobial agents show more promise, but the trial results are inconsistent and the trials have the same methodological problems as do the trials of systemic agents. RCTs of topical antimicrobial agents that use clinically relevant outcomes, a sufficient sample size, and correct methods are urgently needed.

    References

    View Abstract

    Footnotes

    • Source of funding: UK National Health Service.

    • For correspondence: Dr S M O'Meara, NHS Centre for Reviews and Dissemination, University of York, Heslington YO10 5DD, UK. Fax +44 (0)1904 434556.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.